Literature DB >> 6125192

Relationship of plasma catecholamines to blood pressure in hypertensive patients during beta-adrenoceptor blockade with and without intrinsic sympathomimetic activity.

R Kirsten, B Heintz, D Böhmer, K Nelson, S Roth, D Welzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6125192      PMCID： PMC1402173          DOI： 10.1111/j.1365-2125.1982.tb01947.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

Review 1.  Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate.

Authors:  M Laubie; B Delbarre; D Bogaievsky; Y Bogaievsky; D Tsoucaris-Kupfer; D Senon; H Schmitt; H Schmitt
Journal:  Circ Res       Date:  1976-06       Impact factor: 17.367

2.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

3.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

Authors:  J D Peuler; G A Johnson
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

4.  [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].

Authors:  U C Dubach
Journal:  Schweiz Rundsch Med Prax       Date:  1975-09-30

5.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.

Authors:  B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

6.  [Effect of a beta receptor blocker on cardiac output--studies in essential hypertension and hyperkinetic heart syndrome with reference to plasma adrenaline and noradrenaline levels].

Authors:  I Walter; T Kusus; K Wagner; H Lydtin
Journal:  Verh Dtsch Ges Inn Med       Date:  1973

7.  Haemodynamic effects of beta-adrenergic blockade.

Authors:  H Aström
Journal:  Br Heart J       Date:  1968-01

8.  Effects of beta adrenergic blockade on plasma catecholamines in exercise.

Authors:  M H Irving; B J Britton; W G Wood; C Padgham; M Carruthers
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

9.  [The practice of hypertensive therapy using a beta receptor blocker. A multicentric study using 15 mg Visken].

Authors:  J Rosenthal; H Kaiser; D Hammerschmidt; D Welzel
Journal:  Med Welt       Date:  1977-12-02

10.  [Quantitative parameters of sympatho-neuronal and sympatho-adrenal activities in man. The influence of beta-receptor blocking agents (author's transl)].

Authors:  D Palm; H Grobecker
Journal:  Arzneimittelforschung       Date:  1977
View more
  2 in total

1.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol.

Authors:  R Vandongen; B Margetts; N Deklerk; L J Beilin; P Rogers
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.